Similarly, in September 2010, another study rebuffed the use of Venlafaxine and Duloxetine as first-line treatment in major depression, but recommend them as a second line option.
This sign is also sometimes seen as part of a "discontinuation syndrome" associated with certain psychotropic medications, such as serotonin reuptake inhibitors, particularly Paroxetine and Venlafaxine.